# Werewolf Therapeutics, Inc.: Form SCHEDULE 13D/A, filed May 5, 2026

- Company: [Werewolf Therapeutics, Inc.](/companies/howl.md) (CIK 1785530)
- Form: SCHEDULE 13D/A
- Filed: 2026-05-05
- Accepted by EDGAR: May 5, 2026, 19:04 ET
- Period: not reported
- Accession: 0001609492-26-000004
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1785530/000160949226000004/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1785530/000160949226000004/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1785530/000160949226000004/xslSCHEDULE_13D_X02/primary_doc.xml

Filed May 5, 2026.
Source: SEC EDGAR, the filing index for accession 0001609492-26-000004. Last ingested by Listed: Nov 14, 2026, 19:15 ET. No prices; not investment advice.
